Efficacy and safety of first-line treatments for advanced hepatocellular carcinoma patients: a systematic review and network meta-analysis
Article in Frontiers in Immunology (September 2024)
The most recent citing publications are shown below. View all 25 publications that cite this research output on Dimensions.
Efficacy and safety of PD-1 inhibitors plus anti-angiogenesis tyrosine kinase inhibitors with or without transarterial chemo(embolization) for unresectable hepatocellular carcinoma: a meta-analysis
Article in Frontiers in Oncology (August 2024)
Real-world status, efficacy and prognosis analysis of first-line treatment for unresectable hepatocellular carcinoma in patients treated at multiple centres
Article in Annals of Medicine (August 2024)